CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 318 filers reported holding CONCENTRIX CORP in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,163 | -5.2% | 382 | -0.8% | 0.00% | – |
| Q1 2024 | $25,488 | -75.5% | 385 | -63.6% | 0.00% | -100.0% |
| Q4 2023 | $103,888 | +27.5% | 1,058 | +4.0% | 0.00% | 0.0% |
| Q3 2023 | $81,451 | -1.5% | 1,017 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $82,660 | -97.2% | 1,024 | -95.8% | 0.00% | -97.9% |
| Q1 2023 | $2,931,249 | -11.9% | 24,116 | -3.4% | 0.05% | -17.5% |
| Q4 2022 | $3,325,343 | +35.2% | 24,973 | +13.3% | 0.06% | +23.9% |
| Q3 2022 | $2,460,000 | -16.1% | 22,038 | +2.0% | 0.05% | -14.8% |
| Q2 2022 | $2,931,000 | -23.6% | 21,605 | -6.1% | 0.05% | -8.5% |
| Q1 2022 | $3,834,000 | -21.9% | 23,020 | -16.2% | 0.06% | -21.3% |
| Q4 2021 | $4,909,000 | +0.7% | 27,485 | -0.2% | 0.08% | -10.7% |
| Q3 2021 | $4,876,000 | +12.6% | 27,550 | +2.3% | 0.08% | +15.1% |
| Q2 2021 | $4,331,000 | -100.0% | 26,933 | -59.1% | 0.07% | -16.1% |
| Q1 2021 | $9,856,426,000 | +241775.5% | 65,832 | +59.4% | 0.09% | -1.1% |
| Q4 2020 | $4,075,000 | – | 41,287 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |